Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Judge yanks Tagamet ads

Published on .

Johnson & Johnson/Merck Consumer Pharmaceuticals Co. this week was ordered to yank nine of 11 TV commercials and promotional materials for heartburn remedy Pepcid AC. A federal judge agreed with SmithKline Beecham, marketer of competitor Tagamet HB, that details of nine-hour relief and doctors' claims in ads from Compton Partners were problematic. SKB will modify promotional material as a result of a countersuit by J&J/Merck, and agreed not to claim Tagamet controls acid faster than Pepcid. Ogilvy & Mather Worldwide, New York, handles Tagamet.

Most Popular
In this article: